Literature DB >> 20007549

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.

Quynh Mai Le, Heiman F L Wertheim, Nhu Duong Tran, H Rogier van Doorn, Tran Hien Nguyen, Peter Horby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20007549     DOI： 10.1056/NEJMc0910448

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  66 in total

1.  Emerging influenza antiviral resistance threats.

Authors:  Frederick G Hayden; Menno D de Jong
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

2.  Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.

Authors:  Andrés Pizzorno; Xavier Bouhy; Yacine Abed; Guy Boivin
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

3.  Evaluation of three influenza neuraminidase inhibition assays for use in a public health laboratory setting during the 2011-2012 influenza season.

Authors:  William Murtaugh; Lalla Mahaman; Benjamin Healey; Heather Peters; Barbara Anderson; Mandy Tran; Marci Ziese; Maria Paz Carlos
Journal:  Public Health Rep       Date:  2013 Sep-Oct       Impact factor: 2.792

4.  Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance.

Authors:  Elodie Ghedin; Jennifer Laplante; Jay DePasse; David E Wentworth; Roberto P Santos; Martha L Lepow; Joanne Porter; Kathleen Stellrecht; Xudong Lin; Darwin Operario; Sara Griesemer; Adam Fitch; Rebecca A Halpin; Timothy B Stockwell; David J Spiro; Edward C Holmes; Kirsten St George
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

Review 5.  Pandemic influenza: a never-ending story.

Authors:  Seiji Kageyama
Journal:  Yonago Acta Med       Date:  2011-09-01       Impact factor: 1.641

6.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

7.  Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.

Authors:  Elsa Hansen; Troy Day; Julien Arino; Jianhong Wu; Seyed M Moghadas
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

8.  Laboratory capacity building in Asia for infectious disease research: experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN).

Authors:  Heiman F L Wertheim; Pilaipan Puthavathana; Ngoc My Nghiem; H Rogier van Doorn; Trung Vu Nguyen; Hung Viet Pham; Decy Subekti; Syahrial Harun; Suhud Malik; Janet Robinson; Motiur Rahman; Walter Taylor; Niklas Lindegardh; Steve Wignall; Jeremy J Farrar; Menno D de Jong
Journal:  PLoS Med       Date:  2010-04-06       Impact factor: 11.069

9.  Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses.

Authors:  Aaron J Oakley; Susan Barrett; Thomas S Peat; Janet Newman; Victor A Streltsov; Lynne Waddington; Takehiko Saito; Masato Tashiro; Jennifer L McKimm-Breschkin
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

10.  Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets.

Authors:  Susu Duan; David A Boltz; Patrick Seiler; Jiang Li; Karoline Bragstad; Lars P Nielsen; Richard J Webby; Robert G Webster; Elena A Govorkova
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.